Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The epidemiology of amyloidosis in Australia.
Wisniowski B, McLeod D, Adams R, Harvey Y, Armes J, Papadimos D, Brown I, McGuire L, Mollee P. Wisniowski B, et al. Among authors: mollee p. Amyloid. 2019;26(sup1):132-133. doi: 10.1080/13506129.2019.1582481. Amyloid. 2019. PMID: 31343339 No abstract available.
The epidemiology of amyloidosis in Queensland, Australia.
Wisniowski B, McLeod DSA, Adams R, Harvey Y, Brown I, McGuire L, Armes J, Mollee P. Wisniowski B, et al. Among authors: mollee p. Br J Haematol. 2019 Sep;186(6):829-836. doi: 10.1111/bjh.16000. Epub 2019 May 31. Br J Haematol. 2019. PMID: 31148162 Free article. Clinical Trial.
Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
Weber N, Mollee P, Augustson B, Brown R, Catley L, Gibson J, Harrison S, Ho PJ, Horvath N, Jaksic W, Joshua D, Quach H, Roberts AW, Spencer A, Szer J, Talaulikar D, To B, Zannettino A, Prince HM. Weber N, et al. Among authors: mollee p. Intern Med J. 2015 Apr;45(4):371-82. doi: 10.1111/imj.12566. Intern Med J. 2015. PMID: 25169210 Review.
How to diagnose amyloidosis.
Mollee P, Renaut P, Gottlieb D, Goodman H. Mollee P, et al. Intern Med J. 2014 Jan;44(1):7-17. doi: 10.1111/imj.12288. Intern Med J. 2014. PMID: 24024789 Review.
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators. Kastritis E, et al. Among authors: mollee p. N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631. N Engl J Med. 2021. PMID: 34192431 Clinical Trial.
The treatment of paraprotein-related kidney disease.
Hutchison CA, Xiong F, Mollee P. Hutchison CA, et al. Among authors: mollee p. Curr Opin Nephrol Hypertens. 2017 Nov;26(6):477-483. doi: 10.1097/MNH.0000000000000369. Curr Opin Nephrol Hypertens. 2017. PMID: 28885307 Review.
177 results